Broom sweep clean
Biotech

Novo Nordisk drops 2 obesity drugs during pipeline clearout

Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout.
James Waldron Aug 6, 2025 4:44am
GAO

NIH withholding grant funds is illegal, government watchdog says

Aug 6, 2025 11:15am
workers

Fierce Biotech Layoff Tracker 2025: Iovance, Precision & more

Aug 6, 2025 6:00pm
Fierce Fundraising Tracker image 2025

Fierce Biotech Fundraising Tracker: Chai, Artbio & more

Aug 6, 2025 4:15pm
West Virginia University Cancer Institute

WVU Cancer Institute finds place it belongs in Ryght AI network

Aug 6, 2025 12:00pm
heartbeat money acutus IPO

Heartflow pumps up IPO plans to $300M

Aug 6, 2025 11:20am
More News

Flagship’s Alltrna sheds staff as it readies for clinic

Aug 6, 2025 11:04am

Kaken strengthens late-stage HAE portfolio with $32M Astria deal

Aug 6, 2025 10:21am

Contineum shifts cash from MS to lung disease showdown with BMS

Aug 6, 2025 9:51am

Terns vows to stop funding metabolic disease trials beyond 2025

Aug 6, 2025 6:20am